AS

Abhijith Sakunthala Sofji

Active Director Director DIN 08005164
DIN 08005164 First appointment Jan 2018 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Abhijith Sakunthala Sofji

Data last updated:

Abhijith Sakunthala Sofji is a Director at Elixia Biolabs Private Limited (since 2018). The company operates in Trading.

DIN 08005164
Primary Designation Director
Industry Trading
First Appointment 17 Jan 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Elixia Biolabs Private Limited U46309KL2018PTC051813
Director17 Jan 20182018Active

Board colleagues of Abhijith Sakunthala Sofji

NameDINCompanyDesignation
Anoop Nath Raveendranath08002426Elixia Biolabs Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Elixia Biolabs Private Limited
Premium access

Shareholding and investment profile for Abhijith Sakunthala Sofji

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhijith Sakunthala Sofji

Abhijith Sakunthala Sofji currently holds 1 directorship: Elixia Biolabs Private Limited (Director, since 17 Jan 2018).

Abhijith Sakunthala Sofji was first appointed on 17 Jan 2018 as Director at Elixia Biolabs Private Limited.

The current boards of Abhijith Sakunthala Sofji's companies include Anoop Nath Raveendranath (Elixia Biolabs Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available